Grace Therapeutics, Inc. (GRCE) — Institutional Holders, Q2 2026
34 institutional investment managers reported a GRCE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
GRCE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSAdded · +250,998 sh+$569.8K
- Maven Securities LTDNew · +200,000 sh+$454.0K
- CANTOR FITZGERALD, L. P.New · +100,000 sh+$227.0K
- TWO SIGMA INVESTMENTSNew · +96,890 sh+$219.9K
- Birchview CapitalAdded · +70,000 sh+$158.9K
Biggest sellers
- Nantahala Capital ManagementSold out · -728,203 sh-$1.7M
- RENAISSANCE TECHNOLOGIESSold out · -243,910 sh-$553.7K
- MARSHALL WACE, LLPSold out · -91,416 sh-$207.5K
- Connective Capital ManagementSold out · -84,549 sh-$191.9K
- JANE STREET GROUPTrimmed · -77,655 sh-$176.3K
GRCE 13F holders ranked 1–34 of 34
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Cerity Partners#1 · 849,055 sh | 849,055 | $1.9M | <0.01% | 0.0% |
| 2 | Eversept Partners#2 · 772,900 sh | 772,900 | $1.8M | 0.09% | +2.2% |
| 3 | BANK OF AMERICA#3 · 494,698 sh | 494,698 | $1.1M | <0.01% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 411,714 sh | 411,714 | $934.6K | 0.00% | +2.5% |
| 5 | CITADEL ADVISORS#5 · 349,740 sh | 349,740 | $793.9K | <0.01% | +254.2% |
| 6 | Maven Securities LTD#6 · 200,000 sh | 200,000 | $454.0K | <0.01% | New |
| 7 | Birchview Capital#7 · 120,000 sh | 120,000 | $272.4K | 0.13% | +140.0% |
| 8 | CANTOR FITZGERALD, L. P.#8 · 100,000 sh | 100,000 | $227.0K | <0.01% | New |
| 9 | TWO SIGMA INVESTMENTS#9 · 96,890 sh | 96,890 | $219.9K | <0.01% | New |
| 10 | JANE STREET GROUP#10 · 89,442 sh | 89,442 | $203.0K | 0.00% | -46.5% |
| 11 | XTX Topco Ltd#11 · 71,668 sh | 71,668 | $162.7K | <0.01% | +13.6% |
| 12 | HRT FINANCIAL#12 · 62,691 sh | 62,691 | $142.0K | <0.01% | New |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#13 · 49,577 sh | 49,577 | $112.5K | 0.00% | New |
| 14 | BlackRock#14 · 37,535 sh | 37,535 | $85.2K | 0.00% | New |
| 15 | Stonepine Capital Management#15 · 294,550 sh | 294,550 | $62.1K | 0.03% | New |
| 16 | Rangeley Capital#16 · 26,000 sh | 26,000 | $59.0K | 0.05% | New |
| 17 | KESTRA PRIVATE WEALTH SERVICES#17 · 23,000 sh | 23,000 | $52.2K | <0.01% | +76.9% |
| 18 | UBS Group AG#18 · 16,777 sh | 16,777 | $38.1K | 0.00% | -36.2% |
| 19 | Stratos Investment Management#19 · 11,158 sh | 11,158 | $25.3K | <0.01% | New |
| 20 | BNP PARIBAS FINANCIAL MARKETS#20 · 10,500 sh | 10,500 | $23.8K | 0.00% | +47.9% |
| 21 | Scientech Research#21 · 10,184 sh | 10,184 | $23.1K | 0.02% | New |
| 22 | Virtu Financial#22 · 10,166 sh | 10,166 | $23.0K | <0.01% | New |
| 23 | OPPENHEIMER#23 · 10,000 sh | 10,000 | $22.7K | — | 0.0% |
| 24 | MORGAN STANLEY#24 · 9,448 sh | 9,448 | $21.4K | 0.00% | +107.7% |
| 25 | VANGUARD FIDUCIARY#25 · 8,750 sh | 8,750 | $19.9K | 0.00% | 0.0% |
| 26 | NATIONAL BANK OF CANADA#26 · 2,680 sh | 2,680 | $6.1K | 0.00% | -1.3% |
| 27 | WELLS FARGO & COMPANY#27 · 1,800 sh | 1,800 | $4.1K | 0.00% | 0.0% |
| 28 | Tower Research Capital (TRC)#28 · 1,652 sh | 1,652 | $3.8K | <0.01% | +298.1% |
| 29 | SRS Capital Advisors#29 · 1,000 sh | 1,000 | $2.3K | 0.00% | +100.0% |
| 30 | ROYAL BANK OF CANADA#30 · 543 sh | 543 | $1.0K | 0.00% | 0.0% |
| 31 | Activest Wealth Management#31 · 104 sh | 104 | $236.00 | — | 0.0% |
| 32 | SBI Securities , Ltd.#32 · 77 sh | 77 | $175.00 | — | +10.0% |
| 33 | Federation des caisses Desjardins du Quebec#33 · 41 sh | 41 | $93.00 | 0.00% | +4000.0% |
| 34 | NBC SECURITIES#34 · 2 sh | 2 | $4.00 | — | 0.0% |
Funds that sold out of GRCE in Q2 2026 (11)
Held GRCE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Nantahala Capital Management728,203 sh | 728,203 | $3.4M |
| RENAISSANCE TECHNOLOGIES243,910 sh | 243,910 | $1.1M |
| MARSHALL WACE, LLP91,416 sh | 91,416 | $423.3K |
| Connective Capital Management84,549 sh | 84,549 | $391.5K |
| Quadrature Capital Ltd66,822 sh | 66,822 | $309.4K |
| Diametric Capital39,796 sh | 39,796 | $184.3K |
| Pale Fire Capital SE37,762 sh | 37,762 | $174.8K |
| PRELUDE CAPITAL MANAGEMENT10,074 sh | 10,074 | $46.6K |
| GROUP ONE TRADING, L.P.5,000 sh | 5,000 | $23.1K |
| Caitong International Asset Management , Ltd82 sh | 82 | $380.00 |
| Steward Partners Investment Advisory41 sh | 41 | $190.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.